2019\u5e744\u67084\u65e5<\/p>\n
Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva)\u306f\u3001\u76ae\u819a\u79d1\u9818\u57df\u306b\u304a\u3051\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u5927\u624b\u4f01\u696d\u3067\u3042\u308bLEO Pharma\u793e\u304c\u3001\u88fd\u54c1\u958b\u767a\u5168\u4f53\u306e\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u30d7\u30ed\u30bb\u30b9\u3092\u63a8\u9032\u3055\u305b\u308b\u305f\u3081\u306bVeeva Development Cloud<\/a><\/strong>\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63a1\u7528\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u540c\u793e\u306f\u3001Vault Clinical<\/a><\/strong>\u3001Vault RIM<\/a><\/strong>\u3001\u304a\u3088\u3073Vault Quality<\/a><\/strong>\u30b9\u30a4\u30fc\u30c8\u3092\u5229\u7528\u3057\u3066\u533b\u85ac\u54c1\u958b\u767a\u3092\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u7d71\u5408\u3059\u308b\u8a08\u753b\u3067\u3059\u3002Veeva Development Cloud\u306b\u3088\u308a\u3001LEO Pharma\u793e\u306f\u81e8\u5e8a\u8a66\u9a13\u3001\u85ac\u4e8b\u3001\u54c1\u8cea\u696d\u52d9\u7528\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u3057\u3066\u3001\u88fd\u54c1\u958b\u767a\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u306e\u52b9\u7387\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u3055\u3089\u306b\u5411\u4e0a\u3055\u305b\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n LEO Pharma\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u7814\u7a76\u958b\u767a\u62c5\u5f53\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Kim Kj\u00f8ller\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cLEO Pharma\u793e\u306e\u7814\u7a76\u958b\u767a\u3067\u306f2025\u5e74\u306b\u5411\u3051\u305f\u58ee\u5927\u306a\u6226\u7565\u306b\u7740\u624b\u3057\u3066\u304a\u308a\u3001\u76ae\u819a\u79d1\u5b66\u3092\u958b\u62d3\u3057\u7d9a\u3051\u308b\u3068\u3044\u3046\u5927\u671b\u3092\u5b9f\u73fe\u3059\u3079\u304f\u9053\u3092\u958b\u3053\u3046\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u305f\u3081\u306b\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u79d1\u5b66\u3092\u63a8\u9032\u3059\u308b\u540c\u6642\u306b\u3001\u81ea\u793e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u9032\u6357\u3092\u4fdd\u3064\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002Veeva Development Cloud\u306b\u3088\u308a\u3001\u88fd\u54c1\u958b\u767a\u5168\u4f53\u306e\u52b9\u7387\u3092\u6700\u5927\u9650\u306b\u9ad8\u3081\u3001\u76ee\u6a19\u9054\u6210\u306b\u5411\u3051\u3066\u6210\u9577\u306b\u5fdc\u3058\u305f\u62e1\u5f35\u304c\u3067\u304d\u308b\u3001\u7d71\u5408\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u624b\u306b\u5165\u308c\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u88fd\u54c1\u958b\u767a\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u30b9\u30ea\u30e0\u5316\u3057\u3001\u3055\u3089\u306b\u591a\u304f\u306e\u60a3\u8005\u69d8\u306b\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u3092\u8fc5\u901f\u306b\u63d0\u4f9b\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n LEO Pharma\u793e\u306f\u30012025\u5e74\u307e\u3067\u306b1\u51042,500\u4e07\u4eba\u306e\u6162\u6027\u304a\u3088\u3073\u6025\u6027\u76ae\u819a\u75be\u60a3\u60a3\u8005\u306b\u652f\u63f4\u306e\u624b\u3092\u5dee\u3057\u4f38\u3079\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306f\u3001\u533b\u85ac\u54c1\u958b\u767a\u6d3b\u52d5\u3092\u62e1\u5145\u3059\u308b\u305f\u3081\u306b\u5927\u578b\u8cb7\u53ce\u3092\u4f55\u5ea6\u3082\u65ad\u884c\u3057\u3001\u7c73\u56fd\u304a\u3088\u3073\u4e2d\u56fd\u306b\u62e0\u70b9\u3092\u8a2d\u3051\u307e\u3057\u305f\u3002Veeva Development Cloud\u306f\u3001LEO Pharma\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30c1\u30fc\u30e0\u306b\u5358\u4e00\u306e\u88fd\u54c1\u958b\u767a\u60c5\u5831\u6e90\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u5411\u4e0a\u3068\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u9023\u643a\u5f37\u5316\u3092\u5b9f\u73fe\u3057\u307e\u3059\u3002<\/p>\n LEO Pharma\u793e\u30b0\u30ed\u30fc\u30d0\u30ebIT\u90e8\u9580\u306e\u30c7\u30b8\u30bf\u30eb\u30d3\u30b8\u30cd\u30b9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001Mika V\u00e4lil\u00e4\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva\u306f\u5f53\u793e\u306e\u7814\u7a76\u958b\u767a\u696d\u52d9\u5168\u4f53\u306e\u5909\u9769\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u304f\u308c\u3066\u3044\u307e\u3059\u3002Veeva Development Cloud\u306b\u3088\u308a\u3001\u88fd\u54c1\u958b\u767a\u6d3b\u52d5\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u81e8\u5e8a\u8a66\u9a13\u3001\u85ac\u4e8b\u3001\u54c1\u8cea\u696d\u52d9\u306b\u304a\u3051\u308b\u4e00\u8cab\u6027\u3068\u751f\u7523\u6027\u3092\u3088\u308a\u4e00\u5c64\u5411\u4e0a\u3055\u305b\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u300d<\/p>\n \u73fe\u5728\u3001LEO Pharma\u793e\u3067\u306fVault eTMF<\/a><\/strong>\u3001Vault Submissions<\/a><\/strong>\u3001\u304a\u3088\u3073Vault QualityDocs<\/a><\/strong>\u3092\u5229\u7528\u3057\u3066\u3044\u307e\u3059\u30022019\u5e74\u306b\u306f\u3055\u3089\u306b\u3001Vault CTMS<\/a><\/strong>\u3001Vault Study Startup<\/a><\/strong>\u3001Vault Registrations<\/a><\/strong>\u3001Vault QMS<\/a><\/strong>\u3092\u8ffd\u52a0\u3057\u3066\u3001\u5730\u57df\u3084\u90e8\u9580\u3092\u8d85\u3048\u305f\u88fd\u54c1\u958b\u767a\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u306e\u3055\u3089\u306a\u308b\u30b9\u30ea\u30e0\u5316\u3092\u9032\u3081\u308b\u8a08\u753b\u3067\u3059\u3002<\/p>\n Veeva\u306e\u6b27\u5dde\u5730\u57dfVeeva Development Cloud\u6226\u7565\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Rik Van Mol\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cLEO Pharma\u793e\u306f\u3001\u4f01\u696d\u304c\u3044\u304b\u306b\u3057\u3066\u91cd\u8981\u306a\u696d\u52d9\u6a5f\u80fd\u3092\u6700\u65b0\u5316\u3057\u3066\u3044\u304f\u304b\u3092\u793a\u3059\u7d20\u6674\u3089\u3057\u3044\u4f8b\u3067\u3059\u3002Veeva Development Cloud\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u533b\u85ac\u54c1\u958b\u767a\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u30b7\u30b9\u30c6\u30e0\u3001\u30b5\u30a4\u30c8\u3001\u304a\u3088\u3073\u56fd\u306b\u304a\u3051\u308b\u30b5\u30a4\u30ed\u5316\u3092\u89e3\u6d88\u3059\u308b\u305f\u3081\u306e\u57fa\u76e4\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u300d<\/p>\n <\/p>\n \u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e744\u67084\u65e5 Veeva Japan\u682a\u5f0f\u4f1a\u793e Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 …<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42452","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study","blog-product-content-management","blog-product-veeva-rd","blog-product-veeva-vault"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42452"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42452"}],"version-history":[{"count":3,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42452\/revisions"}],"predecessor-version":[{"id":42494,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42452\/revisions\/42494"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>Veeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067700\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2018. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"